SAN DIEGO, Nov. 6, 2019 /PRNewswire/ -- Biocept, Inc.
(NASDAQ: BIOC), a leading commercial provider of liquid biopsy
tests designed to provide physicians with clinically actionable
information to improve the outcomes of patients diagnosed with
cancer, announces that it will release financial results for the
three and nine months ended September 30,
2019 after the market closes on Wednesday, November 13, 2019. The Company
will host a conference call for the investment community to discuss
the results and answer questions at 4:30
p.m. Eastern time (1:30 p.m. Pacific
time).
Individuals interested in participating on the conference call
may do so by dialing (855) 656-0927 for domestic callers, (855)
669-9657 for Canadian callers, or (412) 902-4109 for other
international callers. Those interested in listening to a
webcast of the live conference call may do so by
visiting https://www.webcaster4.com/Webcast/Page/1271/31814.
A replay of the conference call will be available for 48 hours
following the conclusion of the call by dialing (877) 344-7529 for
domestic callers, (855) 669-9658 for Canadian callers, or (412)
317-0088 for other international callers, and entering the replay
access code 10135501. A webcast replay will be available for
90 days at http://ir.biocept.com/events.cfm.
About Biocept
Biocept, Inc. is a molecular diagnostics company with
commercialized assays for lung, breast, gastric, colorectal and
prostate cancers, and melanoma. The Company uses its
proprietary liquid biopsy technology to provide physicians with
clinically actionable information for treating and monitoring
patients diagnosed with cancer. The Company's patented Target
Selector™ liquid biopsy technology platform captures and analyzes
tumor-associated molecular markers in both circulating tumor cells
(CTCs) and in circulating tumor DNA (ctDNA). With thousands
of tests performed, the platform has demonstrated the ability to
identify cancer mutations and alterations to inform physicians
about a patient's disease and therapeutic options. For
additional information, please visit www.biocept.com.
Investor Contact:
LHA Investor
Relations
Jody Cain
Jcain@lhai.com
310-691-7100
View original content to download
multimedia:http://www.prnewswire.com/news-releases/biocept-to-release-third-quarter-2019-financial-results-and-host-investor-conference-call-on-november-13-2019-300952357.html
SOURCE Biocept, Inc.